You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 9, SEPTEMBER 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Assessment of Risk of Overt Nephropathy in Diabetic Patients From Albumin Excretion in Untimed Urine Specimens

Robert G. Nelson, MD, MPH; William C. Knowler, MD, DrPH; David J. Pettitt, MD; Mohammed F. Saad, MD, MRCP; Marie A. Charles, MD; Peter H. Bennett, MB, FRCP, FFCM

Arch Intern Med. 1991;151(9):1761-1765.


Abstract

The ability of an albumin-to-creatinine ratio, measured in a single untimed urine specimen, to indicate the likelihood of developing overt diabetic nephropathy was determined in 439 Pima Indians (134 men, 305 women) aged 25 years or older with non—insulin-dependent diabetes. During a mean follow-up period of 4.2 years, 59 (13%) of the subjects developed overt nephropathy, 47 (80%) of whom had albumin-to-creatinine ratios of 30 mg/g or greater at baseline. Subjects with albumin-to-creatinine ratios of 30 to 299 mg/g (a level of excretion often termed "microalbuminuria") had 9.2 times (95% confidence interval, 4.4 to 21.4 the incidence of overt nephropathy of those with ratios of less than 30 mg/g. Furthermore, the albumin-to-creatinine ratio remained a strong predictor of overt nephropathy even when controlled for age, sex, diabetes duration, mean blood pressure, and 2-hour postload plasma glucose concentration with a proportional-hazards function analysis. Thus, an albumin-to-creatinine ratio measured in a single untimed urine specimen is an effective means of identifying diabetic subjects who are at risk of developing overt nephropathy that could replace the more traditional timed urine collections.

(Arch Intern Med. 1991;151:1761-1765)



Author Affiliations

From the Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation (Dr Nelson), and the Diabetes and Arthritis Epidemiology Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases (Drs Knowler, Pettitt, Saad, Charles, and Bennett), Phoenix, Ariz.


Footnotes

Accepted for publication February 18, 1991.

Presented in part at the 50th Annual Scientific Sessions of the American Diabetes Association, Atlanta, Ga, June 18, 1990.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Aldosterone and progression of kidney disease
Cortinovis et al.
Ther Adv Cardiovasc Dis 2009;3:133-143.
ABSTRACT  

Association of Parental Hypertension With Concentrations of Select Biomarkers in Nonhypertensive Offspring
Lieb et al.
Hypertension 2008;52:381-386.
ABSTRACT | FULL TEXT  

Telemedicine Home Blood Pressure Measurements and Progression of Albuminuria in Elderly People With Diabetes
Palmas et al.
Hypertension 2008;51:1282-1288.
ABSTRACT | FULL TEXT  

Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: The MONICA/KORA Augsburg Echocardiographic Substudy
Lieb et al.
Nephrol Dial Transplant 2006;21:2780-2787.
ABSTRACT | FULL TEXT  

Ambulatory Pulse Pressure and Progression of Urinary Albumin Excretion in Older Patients With Type 2 Diabetes Mellitus
Palmas et al.
Hypertension 2006;48:301-308.
ABSTRACT | FULL TEXT  

Office and Ambulatory Blood Pressure Are Independently Associated With Albuminuria in Older Subjects With Type 2 Diabetes
Moran et al.
Hypertension 2006;47:955-961.
ABSTRACT | FULL TEXT  

Evaluation of tests for microalbuminuria screening in patients with diabetes
Incerti et al.
Nephrol Dial Transplant 2005;20:2402-2407.
ABSTRACT | FULL TEXT  

Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti et al.
NEJM 2004;351:1941-1951.
ABSTRACT | FULL TEXT  

Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans
Young et al.
Diabetes Care 2003;26:2392-2399.
ABSTRACT | FULL TEXT  

Incidence of Retinopathy and Nephropathy in Youth-Onset Compared With Adult-Onset Type 2 Diabetes
Krakoff et al.
Diabetes Care 2003;26:76-81.
ABSTRACT | FULL TEXT  

Serum Homocysteine Levels Are Associated With the Development of (Micro)albuminuria : The Hoorn Study
Jager et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:74-81.
ABSTRACT | FULL TEXT  

Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus
LEMLEY et al.
J. Am. Soc. Nephrol. 2000;11:2095-2105.
ABSTRACT | FULL TEXT  

Microalbuminuria and Carotid Artery Intima-Media Thickness in Nondiabetic and NIDDM Subjects : The Insulin Resistance Atherosclerosis Study (IRAS)
Mykkanen et al.
Stroke 1997;28:1710-1716.
ABSTRACT | FULL TEXT  

Development and Progression of Renal Disease in Pima Indians with Non-Insulin-Dependent Diabetes Mellitus
Nelson et al.
NEJM 1996;335:1636-1642.
ABSTRACT | FULL TEXT  

Albuminuria in Association With Insulin and Sodium-Lithium Countertransport in Young African Americans With Borderline Hypertension
Falkner et al.
Hypertension 1995;25:1315-1321.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.